Home  Secure Resources
Article is 3 years old
Search by: Keyword  Publication    Category  

Special Edition March 2007 - Contents Other issues
Home

Welcome to this special edition of best practice journal which has been produced as part of an education programme for community pharmacists to support the paroxetine brand change.

An abridged version of the original welcome letter can be found here.

Back to the Paroxetine switch home page
Depression - causes, presentation and treatment overview Select
Depression is common, serious and treatable
Multifactorial causes
Presentations vary
Treatment
Mechanism of action
Choosing an antidepressant		 Optimising response
Appropriate dose and duration
Changing drug therapy
Getting well, staying well
Interventions in the pharmacy
References
Depression
Key messages on the use of SSRIs Select
SSRIs
What is bioequivalence Select
bioequivalence
Mental Health Foundation Select
Mental Health Foundation
Drug interactions with antidepressants Select
Drug interactions
The CYP450 system Select
CYP450
Changing to a generic drug Select
Changing
Counselling patients through a brand change Select
Counselling
 About us   Contact us  Home
© bpacnz 2009  Return to top